|
Tijdschrift beschrijving
Alle jaargangen van het bijbehorende tijdschrift
Alle afleveringen van het bijbehorende jaargang
Alle artikelen van de bijbehorende aflevering
63 gevonden resultaten
| nr | titel | auteur | tijdschrift | jaar | jaarg. | afl. | pagina('s) | type |
| 1 | A. Analytical methods |
2001 |
4S3 |
p. S204-S230 27 p. |
artikel |
|||
| 2 | Acknowledgements |
2001 |
4S3 |
p. S7- 1 p. |
artikel |
|||
| 3 | Acknowledgements/Acronyms |
2001 |
4S3 |
p. S3- 1 p. |
artikel |
|||
| 4 | Acronyms and abbreviations |
1997 |
4S3 |
p. S151- 1 p. |
artikel |
|||
| 5 | Acronyms and abbreviations |
1997 |
4S3 |
p. S193- 1 p. |
artikel |
|||
| 6 | 2000 ANNUAL REPORT: ESRD CLINICAL PERFORMANCE MEASURES PROJECT |
2001 |
4S3 |
p. S1- 1 p. |
artikel |
|||
| 7 | B. ESRD network definitions |
2001 |
4S3 |
p. S231- 1 p. |
artikel |
|||
| 8 | 9. Cardiovascular special studies |
2001 |
4S3 |
p. S147-S158 12 p. |
artikel |
|||
| 9 | C. Glossary |
2001 |
4S3 |
p. S232-S235 4 p. |
artikel |
|||
| 10 | 4. Clinical indicators of care |
2001 |
4S3 |
p. S79-S90 12 p. |
artikel |
|||
| 11 | CONTENTS |
2001 |
4S3 |
p. A5- 1 p. |
artikel |
|||
| 12 | Copyright page |
2001 |
4S3 |
p. S2- 1 p. |
artikel |
|||
| 13 | D. USRDS staff & co-investigators |
2001 |
4S3 |
p. S236-S237 2 p. |
artikel |
|||
| 14 | 12. Economic costs of ESRD |
2001 |
4S3 |
p. S181-S194 14 p. |
artikel |
|||
| 15 | END STAGE RENAL DISEASE NETWORKS |
2001 |
4S3 |
p. A6- 1 p. |
artikel |
|||
| 16 | Errata |
1997 |
4S3 |
p. iv- 1 p. |
artikel |
|||
| 17 | E. USRDS products & services |
2001 |
4S3 |
p. S238-S247 10 p. |
artikel |
|||
| 18 | Foreword |
Eknoyan, Garabed |
1997 |
4S3 |
p. S140-S141 2 p. |
artikel |
||
| 19 | General acknowledgments |
1997 |
4S3 |
p. S137- 1 p. |
artikel |
|||
| 20 | I. Anemia work-up |
1997 |
4S3 |
p. S196-S198 3 p. |
artikel |
|||
| 21 | I. Executive summary |
2001 |
4S3 |
p. S8-S12 5 p. |
artikel |
|||
| 22 | II. Background and project methods |
2001 |
4S3 |
p. S12-S19 8 p. |
artikel |
|||
| 23 | III. In-center hemodialysis patients |
2001 |
4S3 |
p. S20-S37 18 p. |
artikel |
|||
| 24 | III. Iron support |
1997 |
4S3 |
p. S202-S212 11 p. |
artikel |
|||
| 25 | III. Prevention of complications: Infection |
1997 |
4S3 |
p. S167-S169 3 p. |
artikel |
|||
| 26 | II. Monitoring and maintenance |
1997 |
4S3 |
p. S162-S166 5 p. |
artikel |
|||
| 27 | II. Target hematocrit/hemoglobin |
1997 |
4S3 |
p. S199-S201 3 p. |
artikel |
|||
| 28 | 1. Incidence & prevalence |
2001 |
4S3 |
p. S37-S52 16 p. |
artikel |
|||
| 29 | 13. International comparisons |
2001 |
4S3 |
p. S195-S200 6 p. |
artikel |
|||
| 30 | Introduction |
1997 |
4S3 |
p. S194-S195 2 p. |
artikel |
|||
| 31 | Introduction |
1997 |
4S3 |
p. S152-S153 2 p. |
artikel |
|||
| 32 | Introduction: The United States Renal Data System |
2001 |
4S3 |
p. S9-S16 8 p. |
artikel |
|||
| 33 | I. Patient evaluation prior to access placement |
1997 |
4S3 |
p. S154-S161 8 p. |
artikel |
|||
| 34 | IV. Administration of epoetin |
1997 |
4S3 |
p. S213-S217 5 p. |
artikel |
|||
| 35 | IV. Management of complications: When to intervene |
1997 |
4S3 |
p. S170-S172 3 p. |
artikel |
|||
| 36 | IV. Peritoneal dialysis patients |
2001 |
4S3 |
p. S38-S46 9 p. |
artikel |
|||
| 37 | IX. References |
1997 |
4S3 |
p. S227-S237 11 p. |
artikel |
|||
| 38 | List of tables/List of figures |
2001 |
4S3 |
p. S4-S7 4 p. |
artikel |
|||
| 39 | 5. Morbidity & hospitalization |
2001 |
4S3 |
p. S91-S106 16 p. |
artikel |
|||
| 40 | NKF-DOQI Advisory council |
1997 |
4S3 |
p. S138- 1 p. |
artikel |
|||
| 41 | NKF-DOQI co-chairs, NKF-DOQI vascular access work group membership, and Anemia work group membership |
1997 |
4S3 |
p. S148-S149 2 p. |
artikel |
|||
| 42 | NKF-DOQI guideline development methodology |
1997 |
4S3 |
p. S142-S147 6 p. |
artikel |
|||
| 43 | NKF-DOQI Steering committee |
1997 |
4S3 |
p. S139- 1 p. |
artikel |
|||
| 44 | 2. Patient characteristics |
2001 |
4S3 |
p. S53-S68 16 p. |
artikel |
|||
| 45 | 6. Pediatric ESRD |
2001 |
4S3 |
p. S107-S116 10 p. |
artikel |
|||
| 46 | Précis: A summary of the United States ESRD program |
2001 |
4S3 |
p. S17-S36 20 p. |
artikel |
|||
| 47 | Preface |
Collins, Allan J |
2001 |
4S3 |
p. v-viii nvt p. |
artikel |
||
| 48 | 10. Preventive health care measures |
2001 |
4S3 |
p. S159-S168 10 p. |
artikel |
|||
| 49 | 11. Provider characteristics |
2001 |
4S3 |
p. S169-S180 12 p. |
artikel |
|||
| 50 | 8. Survival, mortality, & causes of death |
2001 |
4S3 |
p. S135-S146 12 p. |
artikel |
|||
| 51 | 7. Transplantation |
2001 |
4S3 |
p. S117-S134 18 p. |
artikel |
|||
| 52 | 3. Treatment modalities |
2001 |
4S3 |
p. S69-S78 10 p. |
artikel |
|||
| 53 | VI. Appendices |
2001 |
4S3 |
p. S47-S73 27 p. |
artikel |
|||
| 54 | VIII. Biographical sketches of the NKF-DOQI vascular access work group members |
1997 |
4S3 |
p. S190-S191 2 p. |
artikel |
|||
| 55 | VIII. Endnotes |
1997 |
4S3 |
p. S224-S226 3 p. |
artikel |
|||
| 56 | VII. Possible adverse effects related to epoetin therapy |
1997 |
4S3 |
p. S222-S223 2 p. |
artikel |
|||
| 57 | VII. References |
1997 |
4S3 |
p. S184-S189 6 p. |
artikel |
|||
| 58 | V. Inadequate epoetin response |
1997 |
4S3 |
p. S218-S220 3 p. |
artikel |
|||
| 59 | VI. Potential quality of care standards |
1997 |
4S3 |
p. S179-S183 5 p. |
artikel |
|||
| 60 | VI. Role of red blood cell transfusions |
1997 |
4S3 |
p. S221- 1 p. |
artikel |
|||
| 61 | V. Management of complications: Optimal approaches for treating complications |
1997 |
4S3 |
p. S173-S178 6 p. |
artikel |
|||
| 62 | V. References |
2001 |
4S3 |
p. S46- 1 p. |
artikel |
|||
| 63 | X. Biographical sketches of the NKF-DOQI anemia work group members |
1997 |
4S3 |
p. S238-S240 3 p. |
artikel |
63 gevonden resultaten